Kepler Capital Markets set a €48.50 ($59.88) price objective on Carl Zeiss Meditec (ETR:AFX) in a research note released on Monday. The firm currently has a neutral rating on the stock.

Several other brokerages have also recently issued reports on AFX. Berenberg Bank set a €48.00 ($59.26) price target on Carl Zeiss Meditec and gave the company a buy rating in a research note on Tuesday, October 17th. DZ Bank reiterated a sell rating on shares of Carl Zeiss Meditec in a research note on Thursday, October 19th. Deutsche Bank set a €48.00 ($59.26) price target on Carl Zeiss Meditec and gave the company a neutral rating in a research note on Thursday, December 14th. Nord/LB set a €60.00 ($74.07) price target on Carl Zeiss Meditec and gave the company a buy rating in a research note on Tuesday, December 12th. Finally, Independent Research set a €54.00 ($66.67) price objective on shares of Carl Zeiss Meditec and gave the company a neutral rating in a research report on Friday, December 8th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the company’s stock. Carl Zeiss Meditec has an average rating of Hold and an average price target of €52.88 ($65.28).

Shares of Carl Zeiss Meditec (AFX) opened at €49.48 ($61.09) on Monday. The stock has a market capitalization of $4,430.00 and a P/E ratio of 32.77. Carl Zeiss Meditec has a 12 month low of €37.35 ($46.11) and a 12 month high of €55.25 ($68.21).

WARNING: “Carl Zeiss Meditec (AFX) PT Set at €48.50 by Kepler Capital Markets” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another domain, it was illegally copied and republished in violation of international trademark & copyright law. The legal version of this article can be accessed at https://www.thecerbatgem.com/2018/02/15/carl-zeiss-meditec-afx-pt-set-at-48-50-by-kepler-capital-markets.html.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.